Legal & General Group PLC Catalyst Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 313,880 shares of CPRX stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

313,880

Previous 309,491 1.42%

Holding current value

$6.14 Million

Previous $4.93 Million 1.44%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $64,430 - $74,261	4,389 Added 1.42%	313,880 $4.86 Million
Q1 2024 May 14, 2024	BUY	$13.18 - $17.11 $285,689 - $370,876	21,676 Added 7.53%	309,491 $4.93 Million
Q4 2023 Feb 15, 2024	SELL	$11.78 - $17.29 $5,242 - $7,694	-445 Reduced 0.15%	287,815 $4.84 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $82,905 - $106,521	7,092 Added 2.52%	288,260 $3.37 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $478,170 - $751,766	41,580 Added 17.35%	281,168 $3.78 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $5,520 - $8,104	-385 Reduced 0.16%	239,588 $3.97 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $164,738 - $262,236	13,448 Added 5.94%	239,973 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $1.33 Million - $2.93 Million	188,774 Added 500.05%	226,525 $2.91 Million
Q2 2022 Aug 22, 2022	BUY	$6.23 - $8.57 $18,172 - $24,998	2,917 Added 8.37%	37,751 $265,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $94,541 - $117,737	19,493 Added 127.06%	34,834 $185,000
Q2 2021 Aug 12, 2021	SELL	$4.29 - $6.05 $39,824 - $56,162	-9,283 Reduced 37.7%	15,341 $88,000
Q1 2021 May 17, 2021	BUY	$3.45 - $4.69 $37,456 - $50,919	10,857 Added 78.86%	24,624 $114,000
Q3 2020 Nov 13, 2020	SELL	$2.97 - $5.08 $12,738 - $21,788	-4,289 Reduced 23.75%	13,767 $41,000
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $2,902 - $4,211	834 Added 4.84%	18,056 $84,000
Q1 2020 May 14, 2020	SELL	$2.61 - $5.21 $11,314 - $22,585	-4,335 Reduced 20.11%	17,222 $66,000
Q4 2019 Feb 13, 2020	SELL	$3.67 - $5.7 $5,031 - $7,814	-1,371 Reduced 5.98%	21,557 $81,000
Q3 2019 Nov 13, 2019	SELL	$3.89 - $7.43 $4,901 - $9,361	-1,260 Reduced 5.21%	22,928 $121,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $25,515 - $57,739	9,450 Added 64.12%	24,188 $93,000
Q2 2018 Aug 10, 2018	SELL	$2.26 - $3.84 $1,550 - $2,634	-686 Reduced 4.45%	14,738 $46,000
Q1 2018 May 17, 2018	SELL	$2.39 - $4.01 $3,931 - $6,596	-1,645 Reduced 9.64%	15,424 $37,000
Q4 2017 Feb 13, 2018	BUY	$2.51 - $4.4 $42,843 - $75,103	17,069	17,069 $68,000

Others Institutions Holding CPRX

# of Institutions

285

Shares Held

96.6M

Call Options Held

29.2K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.01B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Catalyst Pharmaceuticals, Inc. Transaction History